Skip to main content
OpenTrials

Clinical trial condition

Head and Neck Neoplasms

Explore clinical trials studying Head and Neck Neoplasms. Study availability and eligibility vary by location and protocol.

1,918 public trials 364 recruiting studies
Refine in advanced search Browse all conditions

Head and Neck Neoplasms trial results

Completed

Zalutumumab in Head and Neck Cancer

NCT00093041

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +5 more
Locations
  • Århus Kommunehospital Århus C, Denmark
  • Rigshospitalet Copenhagen Ø, Denmark
  • Odense Universitetshospital Odense, Denmark
  • Universitets Sjukhuset i Lund Lund, Sweden
View Trial Details
Completed

A Phase III Trial Evaluating Chemotherapy and Immunotherapy for Advanced Nasopharyngeal Carcinoma (NPC) Patients

NCT02578641

Conditions
Bone Diseases, Bone Neoplasms, Carcinoma, +25 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • University of California Davis Health Sacramento, California, United States
  • UCSF HDF Comprehensive Cancer Center San Francisco, California, United States
  • Stanford Cancer Center Stanford, California, United States
View all 30 locations
View Trial Details
Completed

Methotrexate Compared With Paclitaxel in Treating Patients With Advanced Head and Neck Cancer

NCT00003592

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Cancer, +11 more
Locations
  • Emory University Hospital - Atlanta Atlanta, Georgia, United States
  • Veterans Affairs Medical Center - Atlanta (Decatur) Decatur, Georgia, United States
  • Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States
  • Veterans Affairs Medical Center - Chicago (Lakeside) Chicago, Illinois, United States
View all 20 locations
View Trial Details
Completed

Analysis of Tumor Tissue and Lymph Nodes Surgically Removed From Patients With Cancers of the Head and Neck

NCT00002695

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Cancer, +6 more
Locations
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
  • Ireland Cancer Center Cleveland, Ohio, United States
  • Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
  • CCOP - Green Bay Green Bay, Wisconsin, United States
View Trial Details
Completed

A Study of the PD-L1xCD27 Bispecific Antibody CDX-527 in Patients With Advanced Malignancies

NCT04440943

Conditions
Adenocarcinoma, Adnexal Diseases, Bladder Urothelial Carcinoma, +61 more
Locations
  • Northside Hospital Atlanta, Georgia, United States
  • University of Chicago Chicago, Illinois, United States
  • Oncology Hematology West, PC dba Nebraska Cancer Specialists Omaha, Nebraska, United States
  • Duke Cancer Center Durham, North Carolina, United States
View Trial Details
Completed

Irinotecan and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer

NCT00040807

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Cancer, +11 more
Locations
  • University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States
  • Stanford Cancer Center at Stanford University Medical Center Stanford, California, United States
  • Medical Center of Aurora - South Campus Aurora, Colorado, United States
  • Boulder Community Hospital Boulder, Colorado, United States
View all 43 locations
View Trial Details
Completed

Paclitaxel in Treating Patients With Advanced Head and Neck Cancer

NCT00002922

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Cancer, +6 more
Locations
  • Veterans Affairs Medical Center - Palo Alto Palo Alto, California, United States
  • Stanford University Medical Center Stanford, California, United States
  • Sylvester Cancer Center, University of Miami Miami, Florida, United States
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
View all 24 locations
View Trial Details

Related conditions